Inhalation flows in adult patient populations, including those with acute asthma

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 10, Issue SUPPL. 1, 1997, Pages

  Crompton, Graham K ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; SALBUTAMOL; TERBUTALINE;

ADULT; ASTHMA; CONFERENCE PAPER; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METERED DOSE INHALER; POWDER INHALER; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME;

EID: 0031051719     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. BROWN PH, NING AC, GREENING AP, MCLEAN A, CROMPTON GK. Peak inspiratory flow through Turbuhaler in acute asthma. Eur Respir J 1995;8:1940-1.
2. DEWAR MH, JAMIESON A, MCLEAN A, CROMPTON GK. Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease. 1996 (submitted for publication).
3. ENGEL T, HEINIG JH, MADSEN F, NIKANDER K. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler®). Eur Respir J 1990;3:1037-41.
4. MEIJER MR, VAN DER MARK T W, AALDERS BJ, POSTMA DS, KOËTER GH. Home assessment of peak inspiratory flow through the Turbohaler in asthmatic patients. Thorax 1996;51:433-4.
5. PERSSON G, OLSSON B, SOLIMAN S. Effect of inhalation effort on peak inspiratory flow through Turbuhaler in asthmatic patients. Eur Respir J 1996;9(Suppl 23):206S.